Jihad S Inshasi

6PUBLICATIONS
26CO-AUTHORS
Nanotoxicology, health and safetyTraditional Chinese medicine and treatmentsMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Chiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 26, 2024
Safety and effectiveness of disease-modifying therapies after switching from natalizumab.

Maya Zeineddine, Raed Al-Roughani, Samar Farouk Ahmed

|Jun 08, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study.

Jihad Inshasi, Samar Farouk, Ahmed Shatila

|Feb 28, 2023
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Cyrus Daruwalla, Vahid Shaygannejad, Serkan Ozakbas

|Nov 30, 2022
External validation of a clinical prediction model in multiple sclerosis.

Nahid Moradi, Sifat Sharmin, Charles B Malpas

|Mar 14, 2022
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review.

Raed Alroughani, Jihad Inshasi, Mona Al Khawajah

|Apr 23, 2021
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates.

Jihad S Inshasi, Sarmed Alfahad, Taoufik Alsaadi

Pageof 1

Frequent Collaborators

3 joint publications

Raed Alroughani

2 joint publications

Tomas Kalincik

1 joint publications

Nahid Moradi

1 joint publications

Cyrus Daruwalla